Bristol Myers Squibb (BMYMP) Shares Repurchased (2017 - 2023)
Bristol Myers Squibb (BMYMP) has disclosed Shares Repurchased for 12 consecutive years, with $4.0 billion as the latest value for Q3 2023.
- Quarterly Shares Repurchased rose 470.61% to $4.0 billion in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Jun 2024, down 6.37% year-over-year, with the annual reading at $5.2 billion for FY2023, 35.57% down from the prior year.
- Shares Repurchased for Q3 2023 was $4.0 billion at Bristol Myers Squibb, up from $905.0 million in the prior quarter.
- The five-year high for Shares Repurchased was $7.0 billion in Q4 2019, with the low at $81.0 million in Q1 2020.
- Average Shares Repurchased over 5 years is $2.0 billion, with a median of $1.4 billion recorded in 2020.
- The sharpest move saw Shares Repurchased surged 2091.36% in 2021, then tumbled 95.0% in 2023.
- Over 5 years, Shares Repurchased stood at $7.0 billion in 2019, then tumbled by 79.07% to $1.5 billion in 2020, then surged by 87.78% to $2.8 billion in 2021, then fell by 12.18% to $2.4 billion in 2022, then surged by 65.56% to $4.0 billion in 2023.
- According to Business Quant data, Shares Repurchased over the past three periods came in at $4.0 billion, $905.0 million, and $250.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.